相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Costunolide inhibits osteosarcoma growth and metastasis via suppressing STAT3 signal pathway
Xinmeng Jin et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation
Mao-xu Ge et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Induction of G2/M Phase Arrest by Diosgenin via Activation of Chk1 Kinase and Cdc25C Regulatory Pathways to Promote Apoptosis in Human Breast Cancer Cells
Wen-Ling Liao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Costunolide Plays an Anti-Neuroinflammation Role in Lipopolysaccharide-Induced BV2 Microglial Activation by Targeting Cyclin-Dependent Kinase 2
Yan-Chen Liu et al.
MOLECULES (2020)
Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer – A comprehensive review from chemotherapy to immunotherapy
Parham Jabbarzadeh Kaboli et al.
PHARMACOLOGICAL RESEARCH (2020)
Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
Xuejiao Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
MDM2 promotes genome instability by ubiquitinating the transcription factor HBP1
Zhengyi . Cao et al.
ONCOGENE (2019)
Costunolide-A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
Dae Yong Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Exosomes in hepatocellular carcinoma: a new horizon
Rui Chen et al.
CELL COMMUNICATION AND SIGNALING (2019)
FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition
Song-Lin He et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer
Weishan Zhuge et al.
CANCER LETTERS (2018)
LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation
Kaixuan Zeng et al.
ONCOGENE (2018)
Reactive Oxygen Species, Superoxide Dimutases, and PTEN-p53-AKT-MDM2 Signaling Loop Network in Mesenchymal Stem/Stromal Cells Regulation
Satoru Matsuda et al.
CELLS (2018)
Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells
Min Hu et al.
GENE (2018)
Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis
S. Liu et al.
ONCOGENE (2017)
Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase
L. E. Giono et al.
ONCOGENE (2017)
Costunolide enhances doxorubicin-induced apoptosis in prostate cancer cells via activated mitogen-activated protein kinases and generation of reactive oxygen species
Jiasheng Chen et al.
ONCOTARGET (2017)
Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway
Zhangxiao Peng et al.
SCIENTIFIC REPORTS (2017)
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapy: Progress and Challenges
Shaomeng Wang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Discovery of Potent and Selective p53-MDM2 Protein-Protein Interaction Inhibitors as Anticancer Drugs
Philipp Holzer
CHIMIA (2017)
PIG3 Regulates p53 Stability by Suppressing Its MDM2-Mediated Ubiquitination
Min Jin et al.
BIOMOLECULES & THERAPEUTICS (2017)
Long non-coding RNA LOC572558 inhibits bladder cancer cell proliferation and tumor growth by regulating the AKT-MDM2-p53 signaling axis
Yiping Zhu et al.
CANCER LETTERS (2016)
Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap
J. Jason Morton et al.
CANCER RESEARCH (2016)
MDM2 Increases Drug Resistance in Cancer Cells by Inducing EMT Independent of p53
Weichao Sun et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Costunolide, a sesquiterpene lactone, inhibits the differentiation of pro-inflammatory CD4+ T cells through the modulation of mitogen-activated protein kinases
Eunchong Park et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Theaflavin-3, 3′-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells
Youying Tu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Costunolide Induces Apoptosis through Generation of ROS and Activation of P53 in Human Esophageal Cancer Eca-109 Cells
Peiyan Hua et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2016)
Reactivation of p53 by MDM2 Inhibitor MI-77301 for the Treatment of Endocrine-Resistant Breast Cancer
Jianfeng Lu et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Costunolide induces G1/S phase arrest and activates mitochondrial-mediated apoptotic pathways in SK-MES 1 human lung squamous carcinoma cells
Peiyan Hua et al.
ONCOLOGY LETTERS (2016)
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial
Hans-Joachim Schmoll et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Inhibition of Wnt/-Catenin Pathway by Dehydrocostus Lactone and Costunolide in Colon Cancer Cells
Guang-zhi Dong et al.
PHYTOTHERAPY RESEARCH (2015)
PI3K/Akt-mediated regulation of p53 in cancer
Aswin G. Abraham et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression
Shaomeng Wang et al.
CANCER RESEARCH (2014)
Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo
T. J. Phesse et al.
CELL DEATH AND DIFFERENTIATION (2014)
Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability
W. Wen et al.
ONCOGENE (2014)
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Mark Wade et al.
NATURE REVIEWS CANCER (2013)
Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-kappa B inhibition
Rebecca A. Whipple et al.
BREAST CANCER RESEARCH (2013)
AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy
M. V. Astle et al.
ONCOGENE (2012)
Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73-and E2F1-mediated expression of PUMA and Siva-1
Ramesh M. Ray et al.
APOPTOSIS (2011)
SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival
N. Fenouille et al.
ONCOGENE (2011)
Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma
E. Drakos et al.
LEUKEMIA (2009)
Therapeutic effect against human xenograft tumors in nude mice by the third generation microtubule stabilizing epothilones
Ting-Chao Chou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells
P. Wang et al.
ONCOGENE (2008)
Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression-transcriptional induction of p21WAF1 and p27kip1 by inhibition of PI-3K/AKT pathway
Hee-Jung Choi et al.
GLYCOBIOLOGY (2006)
Tumor suppression and normal aging in mice with constitutively high p53 activity
SM Mendrysa et al.
GENES & DEVELOPMENT (2006)
Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway
K Rogulski et al.
ONCOGENE (2005)
The p53 pathway: positive and negative feedback loops
SL Harris et al.
ONCOGENE (2005)
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
GL Bond et al.
CELL (2004)
Cancer chemoprevention with dietary phytochemicals
YJ Surh
NATURE REVIEWS CANCER (2003)
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network
LD Mayo et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma
N Itoh et al.
CANCER (2002)
Akt enhances Mdm2-mediated ubiquitination and degradation of p53
Y Ogawara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
R Maya et al.
GENES & DEVELOPMENT (2001)
分享论文
